The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study) | MicrobiomeTrials
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
RecruitingOBSERVATIONAL
Trial Details
Start: 2022-03-30Est. Completion: 2028-06-30
Enrollment target: 261 participants
Locations
Stanford Cancer Institute, Palo Alto, California, United States
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
MD Anderson Cancer Center, Houston, Texas, United States
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Other microbiome trials you might be interested in